tetrodonic acid: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 90472149 |
| MeSH ID | M0164776 |
| Synonym |
|---|
| brn 5804029 |
| tetrodonic acid |
| n6fh6ter4x , |
| 3270-35-7 |
| unii-n6fh6ter4x |
| 1h-4,8a-(epoxymethano)quinazoline-9-carboxylic acid, 2-amino-4,4a,5,6,7,8-hexahydro-5,6,7,8-tetrahydroxy-6-(hydroxymethyl)-, (4s,4ar,5r,6s,7r,8r,8ar,9r)- |
| (4s,4ar,5r,6s,7r,8r,8ar,9r)-2-amino-4,4a,5,6,7,8-hexahydro-5,6,7,8-tetrahydroxy-6-(hydroxymethyl)-1h-4,8a-(epoxymethano)quinazoline-9-carboxylic acid |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.47) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (16.67%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (83.33%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||